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Bnip3Lrated from the sequences surrounding 433 Ser/Thr protein residues whose
phosphorylation by protein kinase CK2 had been previously validated (“bona ﬁde” CK2 phosphosites). This
has been compared to the weblogo extracted from 2275 putative CK2 phosphosites displaying the motif pS/
pT-x1-x2-D/E/pS (where x1≠P) present in the human phosphoElm database including 10899 naturally
occurring phosphosites. The two weblogos are strikingly similar supporting the notion that indeed the 2275
putative sites (accounting for 20.9% of the whole phosphoproteome they belong to), or at least the great
majority of these are generated by CK2. This conclusion has been corroborated by the random validation of 8
of such putative CK2 sites (belonging to 5 different proteins) as real targets of CK2 in vitro and/or in cells,
leading to the inclusion into the repertoire of bona ﬁde CK2 targets of 5 new entries, namely: oxidative
stress-responsive kinase-1, anthrax toxin receptor 1, hepatoma derived growth factor, EpsinR and BCL2/
adenovirus E1B 19 kDa protein-interacting protein 3-like.
© 2009 Elsevier B.V. All rights reserved.1. IntroductionNearly all aspects of life are controlled by the reversible
phosphorylation of seryl, threonyl and tyrosyl residues of proteins
and recently global phosphoproteomic analyses suggest that 50% or
even more proteins are phosphorylated, often at multiple sites [1,2].
Everytime protein phosphorylation takes place, this is catalyzed by
protein kinases, which are members of an individual huge family of
enzymes, numbering over 500 in human and often collectively
referred to as the “kinome” [3]. Given the key role of protein kinases,
committedwith the translation of stimuli and signals into biochemical
events, and playing a paramount role in cell signalling pathways, a
formidable challenge in the proteomic era is to be able to assign each
of the thousands phosphosites of a cell phosphoproteome to the
individual member(s) of the kinome that is/are responsible for its
generation.
It should be noted in this respect that the pleiotropicity of protein
kinases is extremely variable: some of them are dedicated enzymes,
impinging on just one or few substrates (i.e., phosphorylase kinase,ip3L, BCL2/adenovirus E1B 19
se 2; HDGF, hepatoma derived
e kinase-1; TBB, 4,5,6,7-
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ll rights reserved.Wee1 and MEK1), while others are very pleiotropic with hundreds
protein targets subjected to their control. A preliminary classiﬁcation
of phosphosites can be based on local structural determinants which
in the proximity of the target residue generate the so called
“consensus sequence” of each protein kinase [4], a structural motif
whose recognition, in conjunction with several other factors [5]
contributes to the extraordinary selectivity of these enzymes.
A cursory scrutiny of phosphopeptides database [1,2,6] discloses an
unanticipated scenario. The majority of phosphosites appear to be not
generated by basophilic protein kinases (very numerous in the
kinome) but by: i) proline-directed protein kinases, presents in
several sub-branches of the kinome (notably the mitogen activated
kinase and the cyclin dependent kinases) and sharing the absolute
requirement of the S/T-P motif, and by ii) acidophilic Ser/Thr protein
kinases, which represent a tiny minority, with special reference,
among these, to CK2 (formerly denoted by the misnomer “casein
kinase-2”). The minimum consensus of CK2 (S/T-x-x-D/E/pS) is
generally accompanied by additional acidic residues (on the average
more than 5 altogether) and by the absence of basic residues in the
proximity of the target aminoacid [7].
The observation that this individual protein kinase might be
responsible alone for the generation of a substantial proportion of the
eukaryotic phosphoproteome [6] didn't entirely come as a surprise
considering that the continuously growing repertoire of bona ﬁde CK2
substrates already included more than 300 proteins in 2003 [7]
suggesting that it could indeed represent one of the most pleiotropic
members of the kinome.
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many reports showing that its activity is particularly elevated in a
variety of tumors and it plays a global role as a pro-survival and anti-
apoptotic agent (reviewed in [8–12]). The rising concept is that
whenever CK2 reaches a critical threshold it may create a cellular
environment favourable to the establishment and the enhancement of
the tumor phenotype [13].
A breakthrough into our understanding of the biological functions
and pathogenic potential of CK2 will come from a thorough and
detailed compilation of the repertoire of its physiological targets. This
prompted us to elaborate from the more than 400 bona ﬁde
phosphosites generated by CK2 already known a “sequence logo”,
providing a detailed description of sequence similarity around
phosphoresidues [14], and to compare it to the sequence logo
elaborated from the sequences around N2000 putative CK2 sites
(characterized by the motif pS/pT-x-x-E/D) available in the literature.
Here we describe this comparative analysis ending up with the
conclusion that with a few possible exceptions these putative sites
represent real CK2 substrates. We corroborate our conclusions with
the demonstration that 8 putative CK2 phosphoacceptor sites
randomly selected among those never related to CK2 before, can be
actually phosphorylated by CK2.
2. Materials and methods
2.1. cDNA constructs
Full-length human OSR1 cDNA inserted into pCMV5-Myc [15] is a
gift from Melanie H. Cobb (University of Texas Southwestern Medical
Center, Dallas, Texas). Full length human EpsinR inserted into pCMV-
myc [16] is a gift from Prof. Harvey T. McMahon (MRC Laboratory of
Molecular Biology, Cambridge). Full length ANTXR1 inserted in
pcDNA3-HA plasmid [17] is a gift from Prof. Jeremy Mogridge
(Department of Laboratory Medicine and Pathobiology, University of
Toronto, Canada). Full length Bnip3L-HA inserted in pcDNA3.1 [18] is a
gift from Prof. Nicholas C. Denko (Department of Radiation Oncology,
Stanford University School of Medicine, California). Full length human
myc-HDGF inserted inpEF-BOSvectorwaspreparedasdescribed in [19].
The DNAencoding full-lengthHDGFwas ampliﬁed by polymerase chain
reactionwhere EcoRI and XhoI restriction sites have been added to PCR
primer and inserted into the pGEX4T1 vector at EcoRI and XhoI sites.
All mutants were obtained with the QuickChange-Site directed
Mutagenesis kit (Stratagene) according manufacturer instructions.
Mutations were all conﬁrmed by sequencing analysis.
2.2. Recombinant protein expression
All GST epitope tagged fusion proteins were expressed in BL-21
cells. For GST-OSR1, cells were growth at 30 °C to A600 nm=0.5–0.6,
and protein expression was induced with 0.5 mM Isopropyl-1-thio-β-
D-galactopyranoside at 30 °C for 5 h before harvest. For GST-HDGF,
cells were growth at 37 °C to A600nm=0.5–0.6, and protein expression
was induced with 0.5 mM Isopropyl-1-thio-β-D-galactopyranoside at
37 °C for 4 h. Cell were lysed in 50 mM Tris–HCl (pH 8) 1 mM EDTA,
150 mM NaCl and 1% Triton X-100 and by sonication (3 times for 10 s
pulse in an ice bath with a Fisher Sonic Dismembrator 300 set at 35%
maximal energy). After 30 min at 4 °C the lysate was centrifuged at
10000 ×g for 10 min at 4 °C. The supernatant was collected and
incubated with glutathione sepharose 4B resin (GE Healthcare) for 4 h
at 4 °C and extensively washed with PBS. GST-fusion protein was
eluted in 80mMHepes (pH 8) and 10mMGSH. GST-HDGFwas further
puriﬁed by gel-ﬁltration chromatography.
Recombinant human CK2α and α2β2 were expressed and puriﬁed
as in [20]. The activity of the enzymes measured on the peptide
RRRADDSDDDDD is 1000 U/mg for CK2α (in absence of NaCl) and
1500 U/mg for CK2α2β2 (in presence of 100 mM NaCl).2.3. Cell culture and transfection
HEK 293Tcells weremaintained in 5% CO2 in DMEM supplemented
with 10% FBS, 2 mM L-glutamine, 100 U/ml penicillin and 100 mM
streptomycin, in an atmosphere containing 5% CO2.
Cells were plated onto 6-well dishes in a medium without
antibiotics at about 50–60% conﬂuence. The following day cells were
transiently transfected with 3 μg of cDNA by standard calcium-
phosphate procedure [21]. The transfection mixture were removed
after 6 h, the cell monolayers were washed twice and refeed with
complete medium. Cell were lysed after further 48 h.
Transfection efﬁciency monitored in parallel transfections with
pEGFP-C3 (Clontech) was routinely between 30 and 50%.
2.4. Cell lysis and western blot analysis
After incubation, cells (generally between 1 and 2×106 cells) were
detached by gentle pipetting centrifuged, extensively washed with
PBS and lysed by the addition of ice-cold buffer containing 20 mM
Tris–HCl (pH 8), 150 mM NaCl, 2 mM EDTA, 2 mM EGTA, 1% Triton X-
100 (v/v), protease inhibitor cocktail Complete (Roche) and by
sonication (one 10-second pulse in an ice bath with a Fisher Sonic
Dismembrator 300 set at 35% maximal energy). After 20 min
incubation on ice, the lysate was centrifuged 10 min at 10000 ×g at
4 °C. The supernatant was collected and protein concentration was
determined by the Bradford method. Equal amounts of protein were
directly loaded on 10 or 15% SDS/PAGE or used for immunoprecipita-
tion experiments. For Western blotting, proteins were transferred to
Immobilion-P membranes (Millipore) (PVDF) in 3-cyclohexylamino-
l-propanesulfonic acid (CAPS) buffer (10 mM CAPS, 10% methanol, pH
10.0), processed in Western blot with the indicated antibody, and
detected by ECL (enhanced chemiluminescence, Amersham Bios-
ciences). Images were captured with a Kodak Image Station 440CF
(Eastman Kodak, Rochester, NY).
2.5. Antibodies
Monoclonal anti-cMyc antibody (clone 9E10) andmonoclonal anti-
HA antibody (clone HA-7) were purchased from SIGMA. Polyclonal
anti-GST antibody was purchased from Amersham Biosciences.
2.6. Immunoprecipitation and in vitro phosphorylation
For immunoprecipitation, lysate proteins (0.3–0.4mg) where Triton
X-100 concentration was diluted to 0.5%, were incubated with the
indicated antibody for 2 h at 4 °C and thenwith 30 μl of protein G-PLUS-
Agarose (Santa Cruz Biotechnology) beads for 1 h. Beads were washed
three timeswith PBS andone timewith 20mMTris (pH7.5). Beadswere
then incubated in the radioactive mixture consisting in 50mMTris (pH
7.5), 100 μM ATP ([γ-33P]ATP ∼2000 cpm/pmol), and 10 mMMg2+, in
absence (control) or with CK2α or supplemented with 100mMNaCl in
absence or presence of CK2α2β2 at 37 °C for 10 min. The reaction was
stopped with the addition of 2× Laemmli sample buffer, subjected to
SDS/PAGE and blotted on PVDF were indicated. Gels or blots were
exposed overnight to a multipurpose storage phosphor screen and
analyzed using a Cyclone storage phosphor system (Packard).
For the identiﬁcation of the amino acids phosphorylated by CK2 in
HDGF, after phosphorylation sample were hydrolyzed by incubation
for 4 h at 110 °C in 6 N HCl, then subjected to high-voltage paper
electrophoresis at pH 1.9 for 2.5 h, in the presence of non-radioactive
phospho-amino acids as migration reference.
2.7. TBB effect on HDGF CK2-phosphorylation
HEK 293T cells plated onto 6-well dishes at about 50–60%
conﬂuence were transfected with vector alone or with myc-HDGF as
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(about 2×106 cells for well) were treated with 90 μM 4,5,6,7-
tetrabromobenzotriazole (TBB) for 30 min or 40 μM TBB for 2 h or
with DMSO alone (control) before lysis (twowells for each condition).
Cells were lysed as described above with the addition of anti-
phosphatase cocktails I and II (SIGMA) to preserve endogenous phos-
phorylation status of proteins. Myc-HDGFwas immunoprecipitated as
described above from equal amount of cell lysate (0.3–0.4 mg)
obtained from DMSO or TBB treated cells. The immunoprecipitated
was then extensively in vitro phosphorylated by recombinant
CK2α in the radioactive mixture described above ([γ-33P]ATP
∼2000 cpm/pmol) for 60 min at 37 °C. Samples were loaded on
SDS/PAGE gel, blotted on PVDF, processed in Western blot with
the indicated antibody, coomassie stained and the radioactivity
quantiﬁed. Quantitation of the myc-HDGF signal was obtained by
chemiluminescence detection on a Kodak Image Station 440CF and
analyzed with the Kodak 1D image software. Radioactivity was
quantiﬁed with a Cyclone storage phosphor system and OptiQuant
image analysis software (Packard).
2.8. Inhibition of endogenous CK2 activity in cell lysate
After having been either treated or not with TBB, cells were
recovered by centrifugation, lysed as described above, and 1 μg of
proteinswasused for the assay of CK2 activity,measuredby the addition
of the highly speciﬁc peptide substrate RRRADDSDDDDD (0.5 mM) in
the presence of 50 mM Tris–HCl, pH 7.5, 12 mMMgCl2, 100 μM [γ-33P]
ATP (∼1000 c.p.m./pmol) and 0.1 M NaCl, in a total volume of 30 μl.Fig. 1.Web logo analysis of CK2-validated phosphosites. (A) 433 not redundant phosphosite
and phosphoElm database (http://phospho.elm.eu.org/). (B) 110 phosphosites without D/E
was generated using WebLogo 3:Public Beta. In the inset the corresponding frequency plotIncubation was carried out for 10 min at 30 °C, and stopped by sample
spotting on to P81 paper. After washing three times with 0.75%
phosphoric acid, the papers were dried and the radioactivity incorpo-
rated into the P81 paper was counted using a scintillation counter.
3. Results and discussion
The largest individual repertoire of bona ﬁde substrates of protein
kinase CK2 [6] includes 308 phosphosites, belonging to 175 proteins.
The great majority of these sites (88.1%) conform to the consensus for
CK2 for having an acidic residue at position n+3 relative to the
phosphoacceptor aminoacid. Only a tiny minority of these phospho-
sites (9 out of 308) include an individual acidic residue (which in these
cases invariably is at position n+3)whereas 2 or more acidic residues
(on the average more than 5) are found in all the other sites, at
positions spanning between−4 to+7,with the highest frequencies at
n+3 (88.1%) and n+1 (74.5%). This suggests that optimal phosphor-
ylation byCK2 is dictated byacidic clusters rather than byan individual
acidic residue. In contrast basic residues are poorly represented being
nearly absent at positions encompassing n+1 to n+4, where they
were known to act as negative determinants [22]. The same applies to
Pro at position n+1, an essential requirement of Pro-directed kinases
[23], representing however a negative determinant for CK2 as well as
for many others Ser/Thr protein kinases [4].
Additional phosphosites described in the literature for being
generated by CK2 are now available in the phosphosite and
phosphoElm databases amounting altogether 433 entries, belonging
to 286 different proteins (see Table 1 of Supplementary materials)s have been collected from Ref. [7], from phosphosite (http://www.phosphosite.org/)
at n+3 have been extracted from the 433 validated substrates and analyzed. Weblogo
is reported.
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protein kinases. On the other hand, the suspect that this might only
represent the tip of an iceberg and that CK2 is responsible for the
generation of a substantial proportion of the eukaryotic phospho-
proteome would be consistent with a cursory scrutiny of available
phosphopeptides database: the signature of canonical CK2 sites (S/T-
x-x-D/E) is one of the most frequently found [6].
In order to assess howmuch reliable these inferences might be we
have now taken advantage of weblogo, generating sequence logos [14]
which are graphical representations of patterns within a multiple
sequence alignment. Note that sequence logos are more than a way to
merely display consensus sequences, in that they also provide a
detailed description of sequence similarity and can reveal with
immediacy signiﬁcant features of the alignment otherwise difﬁcult
to perceive. Figuratively speaking while the consensus sequence
provides a clue, the sequence logo provides the identikit, if not the
ﬁngerprint of the kinase responsible for its generation.
We reasoned therefore that the sequence logo generated from the
alignment of the 433 bona ﬁde CK2 phosphosites known to date could
become the ﬁrst choice tool to establish if naturally occurring
phosphopeptides exhibiting the CK2 consensus (pS/pT-x-x-D/E) are
likely to be generated by CK2 or not.
To this purpose we ﬁrstly generated the sequence logo for the 434
bona ﬁde CK2 phosphosites previously retrieved, obtaining the
proﬁles reported in Fig. 1A, which recapitulate in an integrated
picture various pieces of information already available. Note that the
logo consists of stacks of letters each denoting an individual
aminoacid residue. While this mode of representation indicates,
with the overall height of each stack, the sequence conservation at
that position, measured in bits, the relative frequency of individual
aminoacids within one stack is better evaluated using another mode
of representation, reported in the inset of the ﬁgure, where all stacks
have been normalized to the same height. The logo conﬁrms that the
most crucial position, reﬂecting in highest sequence conservation, is
the one at n+3, followed by those at n+1 and at n+2, respectively:
in comparison positions upstream, with the exception of n−1, display
a much lower degree of conservation consistent with the old notion
that the speciﬁcity determinants of CK2 are mostly located on the C
terminal side of the target residue [24]. At all positions considered the
two carboxylic side chains of Asp and Glu are predominant reinforcing
the idea that consensus sequences bearing several acidic side chains,
besides the crucial determinant at n+3, are preferentially phos-
phorylated. The frequency of acidic residues at the two “crucial”
positions, n+3 and n+1 reaches 75% and 57%, respectively (Fig. 1A).
In contrast basic residues tend to be negatively selected at all positions
encompassing n−2 to n+5, with special reference to positions n+3
and n+1, where they are virtually absent, but not at positions n−6 to
n−3, consistent with the notion that at these positions they are not
acting as negative determinants and have been actually exploited for
practical reasons in the optimal CK2 peptide substrate,
RRRADDSDDDDD [25]. Pro is negatively selected at position n+1
(b4%), where it is known to act as a negative determinant [24]. Note
that the logo of the atypical sites lacking an acidic residue at position
n+3 is altered: high conservation at this position is entirely lost while
there is an increase in conservation of positions n+2 (now the most
conserved one) and, to a lesser extent n−1, both characterized by a
neat predominance of acidic residues (Fig. 1B). A signiﬁcant rise in
conservation and acidic proportion is also observed at positions n−6
and n+4. This suggests that atypical substrates of this kind, lacking
the canonical consensus, adopt a different mode of binding to the CK2
active site.Fig. 2.Web logo analysis of CK2-putative phosphosites. (A) 2225 phosphosites with D/E at n
339 phosphosites with Pro at n+1 have been extracted from the 2225 phosphosites with D/
from the 2225 phosphosites with D/E at n+3 and analyzed. Weblogo was generated usingWe then moved on to the phosphoElm phosphopeptides database
[26] including one of the largest repertoire of human phosphosites
(10899, belonging to 3310 different proteins) and analyzed it for the
presence of peptides with the pS/pT-x-x-D/E motif which is
suggestive of CK2 mediated phosphorylation. We ended up with
2225 motifs of this sort, representing a large proportion (more than
20%) of thewhole humanphosphoproteome. Next we applied theweb
logo to these putative CK2motifs obtaining the sequence logowhich is
on display in Fig. 2A. Its similarity to the sequence logo derived from
the data base of bona ﬁde CK2 substrates (Fig. 1A) is evident both in
terms of sequence conservation at individual positions and of relative
frequency of individual aminoacids at the most conserved positions.
These, a part from the n+3 position (where the conservation of an
acidic residue was a pre-requisite of our analysis and shouldn't be
considered), were, in the order, positions n+1, n+2, n+4/5, and
n−2, which is almost exactly the same order found in bona ﬁde
CK2 sites. Particularly remarkable is in both logos the predominance
of acidic residues at all these conserved positions, with the frequency
of Glu surpassing that of Asp at positions n+2 and farther down-
stream, whereas Asp predominates at positions n+1 and n−1,
ﬂanking the phosphoacceptor residue where in both logos Ser is more
frequently than Thr (17% and 12% Thr in bona ﬁde and putative
phosphosites, respectively). Another common feature of both logos is
the low frequency of basic residues at positions down-stream, with
special reference to n+1 and n+2.
In contrast a prolyl residue at position n+1, which is quite rare in
the sequence logo of bona ﬁde CK2 substrates (∼2%), rises to almost
9.5% in the logo of the putative CK2 sites database, suggesting a
contamination of this latter by substrates of proline directed protein
kinases which are responsible for the generation of the largest
repertoire of phosphosites, the only one more numerous than that of
potential CK2 targets. Moreover, previously experiments on peptides
phosphorylation showed that proline at n+1 position acts as a
negative determinant [24]. This prompted us to delete these pS/T-P-x-
D/E phosphosites (203 altogether) from the list of putative CK2
phosphosite and to generate the sequence logos for them and for the
remaining putative CK2 phosphosites, separately. As shown in Fig. 2B
the logo of the pS/pT-P-x-E/D phosphosites, a part from the obvious
presence of E/D at n+3 has little to share with the bona ﬁde CK2
phosphosites logo: predominance of acidic residues tend to disappear
as well as conservation of positions n+2, n+4, n+5 and n−1, while
the frequency of prolyl residues increases also at positions other than
n+1 (especially at n−2 and n−1, where it is the most selected and
the second most selected residue, respectively) with basic residues
positively selected at positions n−3 and n−2. These features are
reminiscent of sites affected by Pro-directed kinases either of the ERK
or CDK subfamilies [4]. As expected the logo generated from the 1886
putative CK2 phosphosites devoid of the pS/pT-P motifs (Fig. 2C)
remains very similar to that of bona ﬁde CK2 substrates.
We can therefore conclude that the “identikit” of pS/pT-x1-x2-E/D
sites in which x1≠P, matches very well that of bona ﬁde CK2
phosphosites, thus supporting the view that in the phosphoElm
database, 1886 phosphosites out of 10899 (i.e. almost 17.5%) are most
likely generated by CK2. Note that among these only a tiny minority
displays the features for being phosphorylated by basophilic protein
kinases: those fulﬁlling the motifs recognized by PKA (R/K-R/K-x-S/
T) and PKB/Akt (R-x-R-x-x-S/T) are 5.1% and 3.2%, respectively,
collectively reaching a percentage of 8.2% comparable to that found
among bona ﬁde CK2 substrates (4.8%).
Since on the other hand CK2 phosphorylation can be also primed in
a hierarchical fashion by previously phosphorylated residues which at+3 position have been extracted from human phosphoElm database and analyzed. (B)
E at n+3 and analyzed. (C) 1886 phosphosites without Pro at n+1 have been extracted
WebLogo 3:Public Beta. In the inset the corresponding frequency plot is reported.
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Fig. 4. Phosphorylation of OSR1 by CK2. (A) Multiple sequences alignment was performed by Clustal X. The phosphorylation site is denoted in bold. (B) GST-OSR1 wild type was
incubated in absence or presence of the same units of recombinant CK2α (20 ng) and α2β2 (13.3 ng) (in a radioactive mixture as described in the Materials and methods section).
200 ng of GST-OSR1 (lanes 1 and 2) and 400 ng of GST-OSR1 (lanes 3 and 4) incubated in the absence (lanes 1and 3) or the presence of α2β2 (lanes 2 and 4). 200 ng (lanes 5–6) and
400 ng (lanes 7–8) of GST-OSR1 wild type incubated in absence (lanes 5 and 7) or in presence of CK2α (lanes 6 and 8). Proteins were resolved by SDS/PAGE, coomassie stained, and
analyzed by PhosphorImager. GST-OSR1 appears in SDS/PAGE gel as a double band. The upper band corresponds to the expect molecular mass of the fusion protein (85 kDa) where
the lower band is most likely a partially degraded form of the OSR1 fusion protein that retain autophosphorylation activity as already observed in [13]. In the inset, 5 (1) and 10 ng (2)
of the recombinant protein, runned in SDS-PAGE gel has been blotted and revealed with an anti-GST antibody. (C) Phosphorylation of GST-OSR1 WT and S339A by CK2α (upper
panel) andα2β2 (lower panel). The two forms of OSR1 were incubated in the absence or presence of the same units of recombinant CK2α (20 ng) andα2β2 (13.3 ng). GST-OSR1 wild
type (200 ng in lanes 1–2 and 400 ng in lanes 5–6) were incubated in the radioactive mixture in absence (lanes 1 and 5) or in presence of CK2α or α2β2 (lanes 2 and 6). GST-OSR1
S339A (200 ng in lanes 3–4 and 400 ng in lanes 7–8) were incubated in the radioactive mixture in absence (lanes 3 and 7) or in the presence of CK2α or CK2α2β2 (lanes 4 and 8). (D)
200 (lane 1) or 400 ng (lane 3) of GST-OSR1 wild type and 200 (lane 2) or 400 ng (lane 4) of GST-OSR1 S339Awere incubated for 20 min in a radioactive mixture as described in the
Materials and methods section, loaded in SDS/PAGE gel, coomassie stained and analyzed by PhosphorImager.
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Asp and Glu, we also decided to analyze 582 bisphosphorylated sites
extracted from human phosphoElm database in which the two
phosphoresidues are spaced by two other aminoacids. Assuming in
fact that the down-stream residue is phosphorylated ﬁrst, this would
prime phosphorylation of the upstream one by CK2.
The logo of these bisphosphorylated sites (Fig. 3A) displays
mixed features for being reminiscent on one side of Pro-directed
kinases (conservation of positions n+1 relative to the two
phosphoresidues, with highest frequency of Pro), on the other of
CK2 (conservation of position n+3, with acidic residues positively
selected here as well as at other positions). In an attempt to
discriminate between sites falling in the two categories, the logos of
bisphosphorylated sites having a prolyl residue adjacent to the C-
terminus of the second phosphoresidues or lacking proline at
positions 8 and 11 of the web logo of Fig. 3A, have been generated
(Fig. 3B and C respectively). The former one is clearly reminiscent ofFig. 3.Web logo analysis of phosphodirected CK2-putative phosphosites. (A) 582 phosphosi
database and analyzed. (B) 121 phosphosites displaying the sequence pS/TxxpS/TP have b
phosphosites without Pro adjacent to the C terminus of the two phosphoresidues have been
generated using WebLogo 3:Public Beta. In the inset the corresponding frequency plot is rePro-directed sites, with no similarity to bona ﬁde CK2 sites. The
latter conversely displays the features of bona ﬁde CK2 sites, owing
to predominance of acidic residues at all positions, with special
reference to the most conserved ones, n+3 and n+1 relative to the
priming phosphoresidue. Therefore all the primed phosphosites
conforming to these latter features (389) were also included in the
list of putative phosphosites generated by CK2, totalling 2275 sites
altogether (20.9% of the phosphosites in the human phosphoElm
database). These include more than 70% of the human bona ﬁde CK2
substrates reported to date.
Our present global approach does not allow to discriminate among
different sub-sets of CK2 substrates variably affected e.g. by the α vs.
α′ catalytic subunits, or, even more importantly, susceptible to
opposite regulation by the β subunit. This latter in fact plays a crucial
role in the selection of the targets [27] and the molecular mechanisms
by which it contributes to the recognition of a subset of phosphoac-
ceptor sites is just starting being disclosed [28].tes displaying the sequence pS/TxxpS/T have been extracted from human phosphoElm
een extracted from the above 582 bisphosphorylated peptides and analyzed. (C) 389
extracted from the above 582 bisphosphorylated peptides and analyzed. Weblogo was
ported.
Fig. 5. Phosphorylation of ANTXR1 by CK2. (A) Multiple sequences alignment was performed by Clustal X. The phosphorylation site is denoted in bold. (B) HEK 293T cells were
transfected with vector alone or with HA-ANTXR1 vector. Left panel: 30 μg of cell lysate from control and HA-ANTXR1 transfected cells are loaded in lanes 1 and 2 respectively. The
expected molecular mass of HA-ANTXR1 is ∼65 kDa. Right panel: HA-ANTXR1 is immunoprecipitated from cell lysate and incubated in radioactivemixture in the absence (lane 4) or
in the presence (lane 5) of 0.05 μg of CK2α. HA immunoprecipitation from cells transfectedwith the empty vector is also incubated in the radioactivemixture in presence of 0.05 μg of
CK2α (lane 3). Samples were loaded on SDS/PAGE followed by blotting and analyzed by Western blotting anti-HA (on the left) and by PhosphorImager (on the right).
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While the incontrovertible demonstration that all the i.e. >2000
putative phosphosites listed in Table 2 of Supplementary materials, or
at least the great majority of these, are indeed generated by CK2 will
require a global phosphoproteomic approach, exploiting genetic and/
or pharmacological down-regulation of CK2 in living cells, a ﬁrst
support to this concept could come from the random validation of
some of these sites as effective CK2 targets. To this purpose we have
focused our attention on a number of phosphoproteins which were
not described before as CK2 substrates, making up by the way the
great majority of the proteins listed in Table 2S.
As a preliminary approach a short list of 5 proteins was selected
based on a cursory scrutiny of the protein function and size as well as
on subjective criteria, notably the potential interest of phosphoryla-
tion on one side, and practical issues such as availability of plasmids
and amenability to expression in eukaryotic cells on the other. Two of
the selected proteins contain just one phosphoresidue each while 2
and 3 phosphoresidues are present in two and one of the other three
proteins, respectively.
Collectively taken therefore 8 phosphoresidues falling in the list of
potential CK2 targets have been examined for their actual susceptibility
to CK2 catalyzed phosphorylation. 7 of these are speciﬁed by the S-x-x-
E/D motif, while one is expected to be primed by the previous
phosphorylation of another serine at position n+3 (S-x-x-pS).
3.2. OSR1
Oxidative stress-responsive kinase-1 (OSR1) contains one phos-
phoresidue conforming to the consensus of CK2 (wEwpSDDEfDEE)
[1,29,30].Our interest for this proteinwas triggered by the fact that it is itself
a protein kinase and the putative CK2 phosphoresidue (pS339 in
human) is close to one of two sites (S325) phosphorylated by the
kinases responsible of its activation, the With-no-lysine-kinases
(WNK) 1 and 4 [31]. Moreover this site and the acidic stretch
supporting a potential CK2 phosphorylation are both well conserved
in OSR1 proteins from different organisms (Fig. 4A). It is conceivable
therefore that phosphorylation of S339 by CK2 may contribute to the
regulation of this kinase implicated in a signalling pathway that
protects cells from hyperosmotic stress by phosphorylating and
stimulating the activity of Na+/K+/2Cl co-transporter (NKCC1)
[32]. The same site is also present in STE20/SPS1-related proline/
alanine-rich kinase (SPAK) that is 68% identical in sequence to OSR1
(see Fig. 4A) and have apparently the same role in the signalling
pathway that responds to hyperosmotic stress: it is activated byWNK
phosphorylation at the same regulatory site of OSR1 and it stimulates
NKCC1 activity by phosphorylating the transporter at equivalent
residues [33].
GST tagged OSR1 has been expressed in E. coli to perform in vitro
phosphorylation experiments. The predicted molecular weight of the
fusion protein would be ∼85 kDa. We puriﬁed GST-OSR1 as a doublet
of bands. The molecular weight of the upper one is compatible with
the full length fusion protein, while the lower band could be a C-
terminus degradation product since it is also recognized by an anti-
GST antibody (inset of Fig. 4B) and it displays autophosphorylation
activity (Fig. 4D). As shown in Fig. 4B, the two forms of OSR1 are
readily phosphorylated in a CK2 dependent manner. Both CK2
holoenzyme and its isolated α subunit are able to phosphorylate
OSR1 to a similar extent. Mutation of S339 to Ala abrogates
phosphorylation by the monomeric and tetrameric forms of CK2
(Fig. 4C), thus providing the demonstration that this OSR1 residue
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Fig. 4D we analyze the autophosphorylation activity of the two forms
of OSR1 wild type and mutated by incubating them alone in
radioactive mixture for 20 min. As shown in Fig. 4D, the mutated
protein exhibits a reduced autophosphorylation activity supporting
the hypothesis that the serine which is targeted by CK2 is also
important for the autophosphorylation of OSR1 (Fig. 4D).
3.3. Anthrax toxin receptor 1 (ANTXR1)
The causative agent of anthrax, Bacillus anthracis, releases a
tripartite toxin composed of three proteins: protective antigen (PA),
edema factor (EF) and lethal factor (LF). PA binds to its cellularFig. 6. Phosphorylation of HDGF by CK2. (A) Multiple sequences alignment was performed
transfectedwith vector alone or withwild typemyc-HDGF. Cell lysates were incubatedwith a
immunoprecipitated proteins were incubated in radioactive mixture ([γ-32P]ATP, ∼2000 cp
(lane 1 IP from cells transfectedwith empty vector; lane 2 and 3 IP from cells transfectedwith
of CK2α. Samples were loaded on SDS/PAGE followed by blotting and analyzed by Western
molecular weight of Myc-HDGF is ∼30 kDa but it has an abnormal electrophoretic behavior i
[41]. In the inset: high-voltage paper electrophoresis for the identiﬁcation of the phospho-am
high-voltagepaper electrophoresis, as described inMaterials andmethods section, for the iden
of phosphoaminoacids pSer and pThr, determined by cold standard migration, is shown.
incubated in absence or presence of the same units of recombinant CK2α (20 ng) andα2β2 (13
panel: Phosphorylation kinetics of GST-HDGF. Increasing concentrations of GST-HDGF (1: 2
radioactivemixture ([γ-32P]ATP, ∼2000 cpm/pmol) in presence (1–7) or absence (8) of 20 ng
analyzed by PhosphorImager. Radioactive bands were cut and radioactivity incorporation w
reported). Kmvaluewas calculated fromLineweaver–Burk double reciprocal plots of the data.
the radioactive mixture ([γ-32P]ATP (∼2000 cpm/pmol) instead of [γ-33P]ATP) in presence o
and analyzed by PhosphorImager. Radioactive bandswere cut and radioactivity incorporation
alone, wild type myc-HDGF, or S132/S133A double mutant myc-HDGF. Myc-HDGF WT (lane
radioactivemixture in the presence of 0.05 μg of CK2.Myc immunoprecipitation from cells tra
0.05 μg of CK2α (lane 1). Samples were loaded on SDS/PAGE followed by blotting and analyreceptor, and seven subunits self-associate to form a heptameric ring
which mediates cytoplasmic entry of LF or EF. The two known human
receptors for PA are ANTXR1 (TEM8/ATR) and ANTXR2 (CMG2) [17,
31]. ANTXR1 contains one known phosphoresidue (S362 in human)
located on the cytosolic side, displaying the typical features of a CK2
target (pppaEEpSEEEDDDg) [2]. This site and the acidic determinants
are well conserved (Fig. 5A). The demonstration that this is a real
target of CK2 would add a new entry to the increasing list of CK2
substrates implicated in infectious diseases [34].
HA-ANTXR1 was expressed upon transfection in 293T cells and
immunoprecipitated from cell lysates bymeans of the HA antibody. As
observed in the blot reacted with anti-HA (Fig. 5B) the immunopre-
cipitated protein that exhibits the expected molecular weight of theby Clustal X. The phosphorylation sites are denoted in bold. (B) HEK 293T cells were
nti-myc antibody and precipitatedwith protein G-PLUS-Agarose as described above. The
m/pmol, instead of [γ-33P]ATP to perform the successive phosphoamino acid analysis)
wild typemyc-HDGF) in the absence (lane 2) or in the presence (lanes 1 and 3) of 0.05 μg
blotting anti-myc (on the left) and by PhosphorImager (on the right). The predicted
n SDS/PAGE gels migrating at an higher molecular weight (about 45 kDa) as reported in
inoacid. Radioactive band from lane 3 were cut, hydrolyzed in 6N HCl, and subjected to
tiﬁcation of the phosphoaminoacid. PhosphorImager of the paper is shown. The position
(C) Recombinant GST-HDGF phosphorylation. Upper panel: 200 ng of GST-HDGF was
.3 ng) in a radioactivemixture as described in theMaterials andmethods section. Lower
.3 nM; 2: 4.5 nM; 3: 9 nM; 4: 45.5 nM; 5: 91 nM; 6: 227 nM; 7 and 8: 454 nM) in the
of CK2α for 10 min at 37 °C. Samples were loaded on SDS/PAGE, coomassie stained and
as analyzed in the scintillation counter (mean values±SD of three determinations are
(D) Exhaustive CK2phosphorylation of GST-HDGF.1 pmol of GST-HDGFwas incubated in
r absence of 0.02 μg of CK2α for the time indicated. Samples were loaded on SDS/PAGE
was analyzed in the scintillation counter. (E) HEK 293Tcellswere transfectedwith vector
2) and S132/S133A (lane 3) are immunoprecipitated from cell lysate and incubated in
nsfectedwith the empty vector is also incubated in the radioactivemixture inpresence of
zed by Western blotting anti-myc (on the left) and by PhosphorImager (on the right).
Fig. 7. TBB pre-incubation effect on HDGF CK2-phosphorylation. HEK 293T cells were transfected with vector alone or with wild type myc-HDGF and DMSO or TBB treated as
described in Materials andmethods. Myc-HDGF was immunoprecipitated from cell lysate and exhaustively phosphorylated in radioactivemixturewith the addition of 0.2 μg of CK2α
for 45 min at 37 °C. Samples were loaded on SDS/PAGE followed by blotting and analyzed by Western blotting anti-myc, by PhosphorImager, and coomassie stained. Lane 1:
immunoprecipitation from cells transfected with the empty vector; lane 2: immunoprecipitation from HDGF transfected cells (control); lane 3: immunoprecipitation from HDGF
transfected cells pre-incubated with 90 μM TBB for 30 min; lane 4 immunoprecipitation from HDGF transfected cells pre-incubated with 40 μM TBB for 2 h. Quantitation of the myc-
HDGF signal was obtained by chemiluminescence detection on a Kodak Image Station 440CF and analyzed with the Kodak 1D image software. Radioactivity was quantiﬁed with a
Cyclone storage phosphor system and OptiQuant image analysis software (Packard). Endogenous CK2 activity following TBB incubation was measured as described in Materials and
methods section. The experiment with the most effective conditions (90 μM TBB for 30 min) has been further repeated twice. Statistical analysis (Paired Student's t-test)
demonstrated a signiﬁcant difference in phosphorylation rate between control and TBB treated samples (pb0.01).
Fig. 8. Phosphorylation of EpsinR by CK2. (A) Multiple sequences alignment was performed by Clustal X. The phosphorylation sites are denoted in bold. (B) HEK 293T cells were
transfected with vector alone or with myc-EpsinR. Left panel: 30 μg of cell lysate from control and myc-EpsinR transfected cells are loaded in lane 1 and 2 respectively. The expected
molecular mass of myc-EpsinR is ∼70 kDa. Right panel: Myc-EpsinR was immunoprecipitated from cell lysate and incubated in radioactive mixture in the absence (lane 2) or in the
presence (lanes 3) of 0.05 μg of CK2. Myc immunoprecipitation from cells transfectedwith the empty vector is also incubated in the radioactivemixture in presence of 0.05 μg of CK2α
(lane 1). Samples were loaded on SDS/PAGE followed by blotting and analyzed by Western blotting anti-myc (on the left) and by PhosphorImager (on the right).
856 M. Salvi et al. / Biochimica et Biophysica Acta 1793 (2009) 847–859
Fig. 9. Phosphorylation of Bnip3L by CK2. (A) Multiple sequences alignment was performed by Clustal X. The phosphorylation sites are denoted in bold. (B) HEK 293T cells were
transfected with vector alone or with HA-BNIP3L. HA-BNIP3L was immunoprecipitated from cell lysate and incubated in the radioactive mixture in the absence (lane 2) or in the
presence (lanes 3) of 0.05 μg of CK2α. HA immunoprecipitation from cells transfected with the empty vector is also incubated in the radioactive mixture in presence of 0.05 μg of
CK2α (lane 1). Samples were loaded on SDS/PAGE followed by blotting and analyzed by Western blotting anti-HA (on the left) and by PhosphorImager (on the right). Bnip3L could
migrate as a monomer (∼40 kDa), homodimer (∼80 kDa) or both on SDS/PAGE. The homodimer is DTT-sensitive [42]. In our blot only the dimeric form is visible. This is probably
because the reduction conditions of our Laemmli buffer are not sufﬁcient to observe the monomeric form. This hypothesis is conﬁrmed by the detection of the monomeric form after
pre-incubation of the sample with 50 mM DTT (results not shown). (C) HEK 293T cells were transfected with vector alone, wild type HA-BNIP3L, or S120A mutant HA-BNIP3L. HA-
BNIP3LWT (lane 2) and S120A (lane 3) are immunoprecipitated from cell lysate and incubated in radioactive mixture in the presence of 0.05 μg of CK2. Myc immunoprecipitation
from cells transfected with the empty vector is also incubated in the radioactive mixture in presence of 0.05 μg of CK2α (lane 1). Samples were loaded on SDS/PAGE followed by
blotting and analyzed by Western blotting anti-myc (on the left) and by PhosphorImager (on the right).
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catalytic α subunit. The same applies to a few more mobile
immunoreacting bands probably corresponding to degradation
products of HA-ANTXR1.
3.4. Hepatoma derived growth factor (HDGF)1
This is a ubiquitously expressed 27 kDa heparin binding protein
with mitogenic activity for hepatoma cells, ﬁbroblasts, smooth muscle
cells and endothelial cells [19]. In addition it has been shown to be
neurotrophic. HDGF has been reported to be tumorigenic and a
prognostic factor for a number of cancers [35]. Not less than 10
phosphoresidues have been found in human HDGF, two of which,
adjacent to each other (S132, S133 in human) [1,2,29,30] display the
consensus for CK2 (aEgSSDEEgkl) and are well conserved (Fig. 6A).
HDGF could be easily and abundantly expressed both in eukaryotic
cells and in E. coli. Myc-HDGF transfected in 293T cells and
immunoprecipitated by the myc antibody is readily phosphorylated
at seryl residues by CK2α catalytic subunit (Fig. 6B). A further
investigation with the recombinant form shows that GST-HDGF is
phosphorylated by the monomeric and by the tetrameric form of CK2
to a similar extent (Fig. 6C). Kinetics of phosphorylation (Fig. 6C)
display Km value (142 nM) which is compatible with its physiological
concentration while the phosphorylation stoichiometry shows that1 During the preparation of the manuscript HDGF has been identiﬁed as a CK2
substrate but without the identiﬁcation of the phosphorylation sites (Ref. 40)more than one residue is phosphorylated by CK2 (Fig 6D), consistent
with the presence in it of two phosphorylated residues (S132 and
S133) conforming to the CK2 consensus. The identiﬁcation of these
two residues as those affected by CK2 was conﬁrmed by generating a
double mutant (S132, S133/AA) which is entirely refractory to
phosphorylation (Fig. 6E). The double mutation does not affect the
nuclear localization of HDGF ruling out the possibility that the CK2
phosphorylation site is committed to the regulation of HDGF nuclear
shuttling (results not shown). In a way this was expected because the
sites of phosphorylation are far from the nuclear localization signal.
To gain information about the actual implication of endogenous
CK2 in the phosphorylation of HDGF an assay was performed inwhich
cells transfected withmyc-HDGFwere incubated either in the absence
or presence of TBB, a CK2 speciﬁc inhibitor, prior to lysis, followed by
immunoprecipitation and phosphorylation assay by added CK2α. As
shown in Fig. 7, preincubationwith TBB rendered HDGFmore prone to
phosphorylation as expected assuming that a larger number of
molecules were in the non phosphorylated state owing to the
inhibition of endogenous CK2.
3.5. EpsinR
EpsinR is a 70-kDa protein which speciﬁcally binds to membranes
enriched in phosphatidylinositol-4,5-bisphosphate and may be
implicated in transport via clathrin-coated vesicles from trans-Golgi
network to endosomes [16]. EpsinR is a multiphosphorylated protein
where two phosphorylated residues have been identiﬁed (S232 and
S234 in human) [2] spaced by a single aspartic acid and both
conforming to the consensus sequence of CK2 (percpSDpSDEEkka).
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eukaryotes except in yeast (see Fig. 8A).
Myc-EpsinR has been expressed in 293T cells, immunoprecipitated
by anti-myc antibody and subjected to phosphorylation by CK2α
subunit. The anti-myc blot shows a major band at the expected
molecular weight of the fusion protein (∼70 kDa) that is readily
phosphorylated by CK2α as revealed by PhosphorImager analysis.
3.6. Bnip3L
BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like
(Bnip3L), by interacting with a variety of viral and cellular anti-
apoptotic proteins has been reported to be an inducer of apoptosis
[36]. It has been also proposed that it might function as a tumor
suppressor [37]. Interestingly it seems to play an essential role in
autophagy [38]. Three closely located phosphoserines have been
found in Bnip3L [1, 39] as well as in its related protein Bnip3 showing
∼65% sequence identity [37], and displaying the typical features of
CK2 targets: mhtsrdhpSpSqpSEEEvvEg (Fig. 9A). While however the
second and third serines of the row (S118 and S120 in human) are
primary sites speciﬁed by glutamic acids 121 and 123, respectively,
S117 falls in the category of phosphate directed sites, as its
phosphorylation needs to be primed by previous phosphorylation of
S120. S120 and the acidic determinant at +3 are both conserved
among vertebrates (Fig. 9A).
Bnip3L was expressed in 293T cells, immunoprecipitated, sub-
jected to phosphorylation by CK2α, and immunoprecipitated
proteins were separated by SDS/PAGE. Bnip3L was readily phos-
phorylated by CK2α (Fig. 9B). The phosphorylation site has been
mapped by generating the S120A point mutant and by showing that
this is phosphorylated less than 30% compared to wild type (Fig. 9C).
This ﬁnding is consistent with the hypothesis that all the three
phosphoresidues found in vivo (pS117, pS118, pS120) are also
phosphorylated in vitro by CK2 and that phosphorylation of S120
primes subsequent phosphorylation of S117 but not that of S118
possibly accounting for the residual faint phosphorylation of the
S120A mutant.
4. Conclusions
From a general standpoint our data corroborate the concept that
the weblogo analysis can represent a reliable and powerful tool for the
identiﬁcation of the targets of individual protein kinases within the
large phosphopeptides database made available by advanced phos-
phoproteomic approaches. The feasibility of this task requires the
knowledge of a fairly large number of sites whose phosphorylation by
the kinase of interest has been previously validated (bona ﬁde
phosphosites). It is also made easier if the consensus sequence of the
kinase examined displays distinctive features not shared by other
kinases, as it applies to CK2. In a more speciﬁc vein our data conﬁrm
the feeling that CK2 is probably the most pleiotropic among Ser/Thr
protein kinases, as its typical weblogo, deprived of the consensus for
Pro-directed protein kinases, is still found in 2275 phosphopeptides
out of the 10899 ones present in the human phosphoElm database,
consistent with the view that a substantial proportion of the human
phosphoproteome is indeed generated by this individual kinase.
Finally 8 of these putative CK2 phosphosites have been randomly
validated by conventional biochemical approaches, conﬁrming on one
side the reliability of the predictive analysis based on weblogo, while
adding new facets, on the other, to the complexity of the biological
functions of this pleiotropic kinase.
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